Leon Hooftman's most recent trade in Barinthus Biotherapeutics Plc. - ADR was a trade of 361,530 Ordinary Shares done . Disclosure was reported to the exchange on Sept. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 361,530 | 361,530 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 361,530 | 0 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 195,166 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 140,000 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 140,000 | 140,000 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | 03 Jun 2024 | 195,166 | 195,166 | - | - | Share Option (Right to Buy) |